Pharmacorp Rx (PCRX.V) Performance Overview
Pharmacorp Rx, a Canadian company listed on the TSX Venture Exchange, experienced a decline of 1.84 % during the 24‑hour period ending at 09:30 AM Central Europe on Wednesday 21 September 2026. The share price was approximately CAD 0.40 on the day of reporting.
Market Metrics
- Current share price: CAD 0.40
- Shares outstanding: 195.8 million
- Market capitalization: CAD 80.3 million
- Volume traded (last 24 h): CAD 56.3 k
- 20‑day moving average: CAD 0.46
- 52‑week high: CAD 0.58 (7 June 2026)
- 52‑week low: CAD 0.38 (14 October 2026)
The stock has fallen 2.44 % since the close of the previous month.
Comparative Performance (last 24 h)
| Stock | Ticker | % change | Current price | Market cap | Additional notes |
|---|---|---|---|---|---|
| Infrastructure Sp | IS.TO | +0.96 % | CAD 18.87 | CAD 93 million | – |
| Freeman Gold | FMAN.V | 0 % | CAD 0.30 | CAD 95.1 million | – |
| Tva | TVA‑B.TO | +5.88 % | CAD 2.11 | CAD 92.5 million | P/E ratio 1.9 |
| American Lithium | LI.V | –5.26 % | CAD 0.36 | CAD 94.6 million | – |
| Homeland Nickel | SHL.V | –3.66 % | CAD 0.39 | CAD 94.1 million | – |
Company Profile
Pharmacorp Rx, officially known as Proton Capital Corp, is a Canadian entity listed on the TSX Venture Exchange. The company specializes in the development and distribution of pharmaceutical products.
